Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oronza A Botrugno

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Biochimica Et Biophysica Acta|October 11, 2012
The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemiaMatías Soncini, Fabio Santoro, Arantxa Gutierrez, et al.
Molecular Cell|August 26, 2004
Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferationOronza A Botrugno, Elisabeth Fayard, Jean-Sébastien Annicotte, et al.
Nature|March 4, 2011
HDACs link the DNA damage response, processing of double-strand breaks and autophagyThomas Robert, Fabio Vanoli, Irene Chiolo, et al.
Haematologica|October 15, 2020
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapiesOronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, et al.
Journal of the American Chemical Society|April 27, 2010
Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2Claudia Binda, Sergio Valente, Mauro Romanenghi, et al.
Future Medicinal Chemistry|July 20, 2017
Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia modelPaolo Trifirò, Anna Cappa, Silvia Brambillasca, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell StudiesSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
European Journal of Medicinal Chemistry|September 1, 2014
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1APaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
Blood|February 27, 2013
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenanceFabio Santoro, Oronza A Botrugno, Roberto Dal Zuffo, et al.
Nature Cell Biology|February 22, 2011
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancerRaffaella Di Micco, Gabriele Sulli, Miryana Dobreva, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|October 11, 2012
The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemiaMatías Soncini, Fabio Santoro, Arantxa Gutierrez, et al.
Molecular Cell|August 26, 2004
Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferationOronza A Botrugno, Elisabeth Fayard, Jean-Sébastien Annicotte, et al.
Nature|March 4, 2011
HDACs link the DNA damage response, processing of double-strand breaks and autophagyThomas Robert, Fabio Vanoli, Irene Chiolo, et al.
Haematologica|October 15, 2020
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapiesOronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, et al.
Journal of the American Chemical Society|April 27, 2010
Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2Claudia Binda, Sergio Valente, Mauro Romanenghi, et al.
Future Medicinal Chemistry|July 20, 2017
Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia modelPaolo Trifirò, Anna Cappa, Silvia Brambillasca, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell StudiesSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
European Journal of Medicinal Chemistry|September 1, 2014
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1APaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
Blood|February 27, 2013
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenanceFabio Santoro, Oronza A Botrugno, Roberto Dal Zuffo, et al.
Nature Cell Biology|February 22, 2011
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancerRaffaella Di Micco, Gabriele Sulli, Miryana Dobreva, et al.
Pageof 4